Treatment of progressive brain stem glioma with bevacizumab: radiological, metabolic and histopathological aspects

J Neurol Surg A Cent Eur Neurosurg. 2012 May;73(3):187-91. doi: 10.1055/s-0032-1313633. Epub 2012 May 24.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Astrocytoma / metabolism
  • Astrocytoma / pathology
  • Astrocytoma / therapy*
  • Bevacizumab
  • Biopsy
  • Brain Stem Neoplasms / metabolism
  • Brain Stem Neoplasms / pathology
  • Brain Stem Neoplasms / therapy*
  • Combined Modality Therapy
  • DNA Modification Methylases / metabolism
  • DNA Repair Enzymes / metabolism
  • Dizziness / etiology
  • Female
  • Gait Disorders, Neurologic / etiology
  • Glioma / metabolism
  • Glioma / pathology
  • Glioma / therapy*
  • Humans
  • Immunohistochemistry
  • Magnetic Resonance Imaging
  • Molecular Biology
  • Nausea / etiology
  • Neurosurgical Procedures
  • Positron-Emission Tomography
  • Stereotaxic Techniques
  • Tumor Suppressor Proteins / metabolism
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Tumor Suppressor Proteins
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • DNA Modification Methylases
  • MGMT protein, human
  • DNA Repair Enzymes